Articles related to PRACTICE MANAGEMENT

Oncology Medical Home (OMH) is a system of care delivery that features coordinated, efficient, accessible, and evidence-based care and includes a process for measurement of outcomes to facilitate continuous quality improvement. OMH can serve as a roadmap to guide how a practice delivers high-quality oncology care (a process of practice transformation) and support (but not define) new models of value-based reimbursement.

An extremely interesting case in New York is examined in this article, which chronicles a female patient suffering from multiple sclerosis and her suit against her neurologist for prescribing a new medication that her attorney feels goes beyond medical malpractice and into fraud under NY’s General Business Law 349: “deceptive acts or practices in the conduct of any business, trade or commerce or in the furnishing of any service in this state are hereby declared unlawful.”

In this article/podcast from KevinMD.com, the author encourages readers to make some adjustments in their life to reduce the professional and personal risks associated with the stakeholders who target physicians, including corporate America, the government, patients, and the financial industry. The commentary is a response to President Biden’s multi-trillion spending plan, which targets rich corporations and wealthy individual Americans making more than $400,000.

In this article/podcast from KevinMD.com, Dr. Kristin Yates, an OB/GYN, describes her work as a doctor, which “brings me fulfillment and joy. It makes me a better doctor.” Dr. Yates also explains: “The fact of the matter is, I am not a doctor. I am a human being. Doctoring is what I do, not who I am. This distinction is very important to me because it is what has made medicine sustainable and fulfilling.”

Are you biased toward certain types of patients? “Sometimes” is likely your answer, but there are implicit biases that doctors may not be aware they have. To help answer this question, Medscape put together a survey to weigh these biases, with emotional problems coming in at No. 1. Whether they are implicit or explicit, here are the other patient characteristics that commonly trigger a predisposition in doctors. 

The first biologic was approved in 1982, and since then, have become one of the fastest-growing segments of the US pharmaceutical market. Biologics are complex therapies used to treat a wide variety of conditions – conditions that are often untreatable by any other drug – and physicians should be up to speed on these four classes of biologic agents, which are used to treat cancer or inflammatory disease.